...
机译:复发性上皮性卵巢癌患者联合CKD-602和顺铂联合化疗的I / IIa期研究
Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Korea;
Center for Uterine Cancer, National Cancer Center, Goyang-si, Korea;
Center for Uterine Cancer, National Cancer Center, Goyang-si, Korea;
Department of Obstetrics and Gynecology, College of Medicine, Chung-Ang University, Seoul, Korea;
Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Korea Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea;
Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Korea Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea;
Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Korea;
Department of Obstetrics and Gynecology, Konkuk University Hospital, Seoul, Korea;
Deparl-ment of Obstetrics and Gynecology, College of Medicine, Seoul National University, 28 Yeongun-Dong, Jongno-Gu Seoul, 110-744, Korea Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea Major in Biomodulation, World Class University, Seoul National University, Seoul, Korea;
ovarian cancer; recurrent; CKD-602; cisplatin;
机译:bryostatin-1与顺铂联合治疗复发性或持续性上皮性卵巢癌的II期临床试验:加利福尼亚癌症协会的一项研究。
机译:HIPEC ROC I:对铂敏感的复发性上皮性卵巢癌患者进行顺铂腹腔内高温热灌注化疗,然后进行基于静脉铂金化疗的I期研究
机译:HIPEC ROC I:对铂敏感的复发性上皮性卵巢癌患者进行顺铂作为高温术中腹膜内化疗,然后进行基于静脉铂铂的化疗的I期研究
机译:大剂量化学疗法和自体干细胞拯救治疗的Theratope(STn-KLH)癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果:自体移植后的Theratope(STn-KLH)癌症疫苗
机译:通过差异显示(EDD)鉴定的E3连接酶可增强上皮性卵巢癌和口腔鳞状细胞癌的细胞存活率和顺铂耐药性。
机译:Bryostatin-1的第二阶段试验与复发性或持续上皮卵巢癌症患者的顺铂组合:加州癌症联盟研究
机译:HIPEC ROC I:I阶段研究称为高温术中腹膜内校长的顺铂,然后术后术后静脉内铂类化疗,铂敏感复发性上皮卵巢癌患者